Feature | Computed Tomography (CT) | November 05, 2018 | By Melinda Taschetta-Millane

Computed Tomography Holds Steady in Market

This article originally ran as an introduction to the Computed Tomography comparison chart in the November/December 2018 issue. You can view the chart here.

The NeuViz 16 Essence from Neusoft Medical Systems.

The NeuViz 16 Essence from Neusoft Medical Systems.

According to an industry market report released by Mordor Intelligence in May 2018, the computed tomography (CT) market is expected to achieve a compound annual growth rate (CAGR) of 5.4 percent during the forecast period of 2018-2023. CT systems use a series of X-ray images to create an image volume dataset with slices that can be manipulated on any plane using advanced visualization software.

The report states that due to an increase in incidence of cancer and other chronic diseases — including heart disease, diabetes, stroke and arthritis — the demand for CT is on the rise, stating that “Cardiovascular diseases account for 17.5 million deaths annually, followed by cancers (8.2 million), and it is estimated that nearly 550,000 new cases of head and neck cancer are diagnosed globally each year.” Other factors driving the CT market include the growing global aging population, technological advances and more of an awareness for healthcare overall.

Reimbursement is a topic that remains on the front burner in today’s economy. “CT reimbursements have been cut substantially. Imaging facilities are squeezing more life from their computed tomography scanners in response to lower reimbursement,” according to Mordor Intelligence. “The Centers for Medicare and Medicaid Services recently declared a reduced reimbursement for CT by 21 percent and MRI by 12 percent, respectively. The cost of any treatment in the public sector is determined by the set scale of fees for individual cost operations and by a sliding scale of reimbursement. However, in the private sector, the cost of treatment is highly unchecked. This adds to the patients’ expenditure as only a fixed amount or a part of expenses are reimbursed, which is a major restraint for the market. The other restraint for the CT market is the expensive procedures and equipment.”

Market Update

At the recent American Society of Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas, Canon Medical Systems showcased its newly FDA-cleared Aquilion Precision, an ultra-high resolution CT system. It can resolve anatomy as small as 150 microns and is designed to provide more than twice the CT resolution as standard systems. Containing an all-new detector as well as tube, gantry and reconstruction technologies, the system may make it possible to
help expand visualization of disease thanks to new features that offer improved image detail. The Aquilion Precision CT system features innovative dose efficiency with detector channels that are only 0.25 mm thick. This combined with substantial improvements in scintillator quantum efficiency, detector circuitry and other DAS components, results in a dose-efficient detector with ultra-high resolution capabilities.

Siemens Healthineers recently installed its first Somatom go.Top computed tomography (CT) system at the Ohio State University Wexner Medical Center in Columbus. The 128-slice scanner expands the Somatom go.CT platform’s concept of patient-centric mobile workflow, which is controlled via tablet and remote, into advanced clinical fields and applications, including cardiology, CT-guided intervention and dual-energy spectral imaging.

In addition to a 0.33-second rotation time, stellar detector technology and a 75 kW generator, the Somatom go.Top has a large detector with an acquisition speed of up to 175 mm in one second and an automated workflow. The system can deliver new levels of radiation dose personalization due to its high power and low kV scanning mode, along with automated tools that take the guesswork out of low-dose CT imaging. And with the system’s mobile, tablet-based workflow and the capability to off-load manual reconstruction tasks, technologists can spend more time focused on the patient.

And at the 2018 Association for Medical Imaging Management (AHRA) Annual Meeting in July, Neusoft Medical Systems introduced the NeuViz 16 Essence. It is a 16-slice CT system designed to elevate routine imaging for exceptional results, ideally suited for U.S. healthcare providers. The NeuViz 16 Essence technology is built with the same ease of use and reliability of the mature NeuViz 16 CT system, plus the recent technical innovations developed for the NeuViz 128 CT platform, including a full complement of advanced applications at no additional cost. Additionally, patient-centered features include a wider bore, optimal gantry tilt and a minimal couch height of 43 cm to provide easy access for all patients. The NeuViz 16 Essence is also fully compliant with XR-29 standards in accordance with the Medical Imaging Technology Alliance (MITA) Smart Dose campaign to advance low-dose imaging technology.

 

Reference

Modor Intelligence, “Computed Tomography (CT) Market - Segmented By Product, Application, End User, and Geography - Growth, Trends, and Forecast (2018 — 2023),” May 2018. https://www.mordorintelligence.

Related Content

C-RAD has been selected as the partner to implement surface tracking technology for three proton cancer treatment centers in the U.S.
News | Proton Therapy | December 28, 2020
December 28, 2020 — C-RAD offers a specific version of its Catalyst System for use in...
The key trends oClinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at  the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | December 17, 2020 | By Melinda Taschetta-Millane and Dave Fornell
Post-neoadjuvant therapy changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma

Pre-treatment (A-C) and post-treatment (D-F) images after eight cycles of systemic FOLFIRINOX and consolidative chemoradiation. Baseline CA 19-9 was 145 U/ml. Pre-treatment whole body axial fused PET/MRI showed FDG avid lesion in body of pancreas (arrow, A) with SUVmax 7.1 and SUVgluc 8.0. Lesion was hypo-enhancing on axial contrast-enhanced T1-weighted (T1W) MR image (arrow, B) from focused abdominal PET/MRI and on CT (arrow, C). Pre-treatment CT tumor volume was 10.3 cm3. Post-treatment whole body axial fused PET/MRI showed complete metabolic response (arrow D) with SUVmax 1.9 and SUVgluc 1.9. Lesion was indistinct on axial contrast-enhanced T1W MRI (arrow, E) and CT (arrow, F), and there was upstream pancreatic parenchymal atrophy. Post-treatment CT tumor volume was 0.46 cm3. There was normalization of CA 19-9. Relative change in SUVmax (ΔSUVgluc) was -73%, and relative change in SUVgluc (ΔSUVgluc) was -76%. Based on change in tumor size, response was categorized as partial response per RECIST. Relative change in tumor volume (ΔTvol) was -96%. Pathology showed major pathologic response (College of American Pathologists score 1.) Images courtesy of American Roentgen Ray Society (ARRS), American Journal of Roentgenology (AJR)

News | PET-MRI | December 10, 2020
December 10, 2020 — According to an open...
An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

An MR image of a patient in their early 20s shows nerve injury (highlighted in yellow) of the left brachial plexus in the neck. The patient experienced left arm weakness and pain after recovering from COVID-19 respiratory illness, which prompted them to see their primary care physician. As a result of the MRI findings, the patient was referred to the COVID-19 neurology clinic for treatment. Image courtesy of Northwestern University

News | Coronavirus (COVID-19) | December 08, 2020
December 8, 2020 — After recovering from COVID-19
Earlier initial diagnosis reduces lung cancer mortality in heavy (ex-)smokers / The risk of harm from misdiagnosis or overdiagnosis is relatively low

Image courtesy of Toshiba/Canon

News | Computed Tomography (CT) | December 08, 2020
December 8, 2020 — For heavy (ex-)smokers,...
The company’s ClearRead Xray Confirm (Enhanced) and ClearRead CT – breakthrough lung nodule detection applications­ – have received clearance for sale in Australia
News | Computed Tomography (CT) | December 03, 2020
December 3, 2020 — Riverain Technologies, a U.S.-based developer of...
Advanced imaging with computed tomography (CT) shows that people who cook with biomass fuels like wood are at risk of suffering considerable damage to their lungs from breathing in dangerous concentrations of pollutants and bacterial toxins, according to a study being presented at the annual meeting of the Radiological Society of North America (RSNA).

Kitchen location showing the cooking stove and wood fuels used; there is a lack of sufficient ventilation to clear the smoke by-products from biomass fuel use. Image courtesy of Radiological Society of North America

News | Computed Tomography (CT) | December 03, 2020
December 3, 2020 — Advanced imaging with comput...